Categories
Loading...
Categories
ZIM Laboratories Limited has entered into a strategic collaboration with Globalpharma Co. (L.L.C.) to commercialize Oral Thin Film (OTF) products in the Gulf Cooperation Council (GCC) region. This agreement encompasses dossier licensing, bulk product supply, and licensing of ZIM's proprietary ThinOral® technology. Globalpharma will register and commercialize 10 OTF-based pharmaceutical and nutraceutical products developed by ZIM, focusing on regional patient needs with innovative dosages. ZIM will initially supply bulk products and provide regulatory support in the UAE, followed by ready-to-use powder mixes for Globalpharma's local manufacturing. This partnership is expected to enhance ZIM’s market presence in the rapidly growing Middle Eastern pharmaceutical market, presenting a positive outlook for both companies as they aim to deliver high-quality, user-friendly solutions to patients.